Related Experiment Video
Updated: May 3, 2026
09:04
Foodborne Pathogen Screening Using Magneto-fluorescent Nanosensor: Rapid Detection of E. Coli O157:H7
Published on: September 17, 2017
7.6K
Waveguide-Enhanced Nanoplasmonic Biosensor for Ultrasensitive and Rapid DNA Detection
Devesh Barshilia1, Akhil Chandrakanth Komaram2, Lai-Kwan Chau2
1Department of Mechanical Engineering and Advanced Institute of Manufacturing with High-Tech Innovations, National Chung Cheng University, Chiayi 621301, Taiwan.
Micromachines
|September 28, 2024
Summary
A new DNA biosensor uses gold nanoparticles and waveguides for rapid, enzyme-free detection. This ultrasensitive, cost-effective technology offers a promising tool for early disease diagnosis and clinical applications.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Molecular Biology
Background:
- DNA and RNA sequence analysis is crucial for diagnostics, gene expression monitoring, and pathogen detection.
- Traditional methods like PCR and NGS are complex, costly, and require advanced computational skills.
- There is a need for rapid, low-cost, enzyme-free, and amplification-free DNA detection strategies.
Purpose of the Study:
- To develop a novel DNA-functionalized waveguide-enhanced nanoplasmonic optofluidic biosensor.
- To achieve enzyme-free and amplification-free DNA detection with high sensitivity and speed.
- To create a cost-effective and clinically applicable DNA detection platform.
Main Methods:
- Fabrication of a biosensor integrating gold nanoparticles (AuNPs) with a glass planar waveguide (WG) and microfluidic channel using vacuum-free methods.
- Development of a nanogold-linked sorbent assay with a sandwich architecture for specific DNA target detection.
- Utilizing AuNPs labeled with DNA probes to enhance sensitivity via evanescent wave manipulation and plasmon resonance.
Main Results:
- The biosensor achieved specific detection of complementary DNA sequences.
- Demonstrated an ultrasensitive limit of detection (LOD) of 33.1 fg/mL (4.36 fM).
- Exhibited a rapid response time of approximately 8 minutes with minimal nonspecific adsorption.
Conclusions:
- The developed biosensor is ultrasensitive, rapid, cost-effective, and suitable for clinical applications.
- The innovative design and fabrication are advantageous for mass production.
- This technology presents a viable tool for precise disease diagnostics and improved clinical outcomes.
